TYRP1 and melanoma: We proposed a method of shortened ex vivo expansion using Th17 cells to treat melanoma using the TRP-1 transgenic mouse model in which CD4+ T cells express a TCR that recognizes tyrosinase-related protein 1 on melanoma.